Sign Up for Our Newsletter!

Stay connected with ZERO Prostate Cancer through our newsletter below:

Name

🎁 $75,000 HOLIDAY MATCH IS LIVE🎁

Make a gift during the season of giving!

EOY Giving 2025 Match Your Gift

HELP 🔓 $100,000 IN LIFESAVING SUPPORT 💙

ONE DAY ONLY: Help ZERO raise $20,000

and unlock Harrity & Harrity's $80,000 match!

H4C EOY Giving Donate Now
Banner_Prostate Cancer News

U.S. Metastatic Prostate Cancer Diagnoses Increase After Reduction in PSA Screening

Blue sterile gloves holding a petri dish

A reduction in prostate-specific antigen (PSA) screening in men aged 40 years and older was associated with an increase in metastatic prostate cancer diagnoses in the United States, according to results of a study presented at the 2021 ASCO Genitourinary Cancers Symposium.

Between 2008 and 2016, across all states, the mean percentage of men undergoing PSA screening decreased from 61.8% to 50.5%, while the mean incidence of metastatic prostate cancer at diagnosis increased from 6.4 to 9.0 per 100,000 (adjusted P<0.001 for both) (abstract 228).

Read the full article here. 


source: Clinical Oncology

Read More About Prostate Cancer

Enjoy our library of additional news articles, our Journey to ZERO blog, and our ZEROHour newsletter.

Share